TC
MRVI icon

Tejara Capital’s Maravai LifeSciences MRVI Stock Holding History

Tejara Capital’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.95M Sell
1,595,345
-1,899,842
-54% -$8.2M 4.09% 5
2026
Q1 		$9.89M Buy
3,495,187
+474,978
+16% +$1.61M 3.26% 6
2025
Q4 		$9.82M Buy
3,020,209
+566,768
+23% +$1.91M 2.31% 6
2025
Q3 		$7.04M Buy
2,453,441
+511,992
+26% +$1.31M 3.67% 9
2025
Q2 		$4.68M Buy
1,941,449
+1,398,900
+258% +$2.94M 2.17% 12
2025
Q1 		$1.2M Buy
+542,549
New +$2.14M 0.46% 51

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Tejara Capital's MRVI Position: Q2 2026 in Review

Tejara Capital reduced its Maravai LifeSciences (MRVI) stake by 54% in Q2 2026, selling an estimated $8.2M and leaving 1,595,345 shares worth $9.95M. The position accounts for 4.09% of the portfolio, ranked #5.

Tejara Capital first reported a position in MRVI in Q1 2025 and has held it in 6 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Tejara Capital held 1,595,345 shares of Maravai LifeSciences worth $9.95M as of Q2 2026.
  • Tejara Capital sold 1,899,842 Maravai LifeSciences shares in Q2 2026, an estimated $8.2M.
  • Maravai LifeSciences made up 4.09% of Tejara Capital's portfolio in Q2 2026, its #5 holding.
  • Tejara Capital first reported a position in Maravai LifeSciences in Q1 2025 and has held it in 6 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Tejara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.